Concepedia

Self‐evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

Danilo Galizia, Andrea Milani, Elena Geuna, Rossella Martinello, Celeste Cagnazzo, Manuela Foresto, Virginia Longo, Paola Berchialla, Gianfranca Solinas, Adele Calori,

Cancer Medicine · 2018 · 47 citations · 20 references

DOIFull text

Open access

Abstract

Self-reporting TSE duration is feasible using a CTCAE-derived questionnaire. As doctors tend to underestimate TSE incidence and duration, patient-reported outcomes should be incorporated into clinical practice, perhaps using eHealth technologies, to harness their potential to better estimate total TSE burden.

References

20

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text

, , +19

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

Ethan Basch, Alexia Iasonos, Tiffani L. McDonough et al. · The Lancet Oncology · 2006 · 646 citations

, , +9

Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

Ethan Basch, Xiaoyu Jia, Glenn Heller et al. · JNCI Journal of the National Cancer Institute · 2009 · 615 citations · Full text

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Erik K. Fromme, Kristine M. Eilers, Motomi Mori et al. · Journal of Clinical Oncology · 2004 · 553 citations

Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

Massimo Di Maïo, Ciro Gallo, Natasha B. Leighl et al. · Journal of Clinical Oncology · 2015 · 478 citations · Full text